New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - roxithromycin 150mg;   - coated tablet - 150 mg - active: roxithromycin 150mg   excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch povidone propylene glycol purified talc titanium dioxide water - adults roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible micro-organisms: · upper respiratory tract infection - acute pharyngitis, tonsillitis and sinusitis · dental infections · lower respiratory tract infection - acute bronchitis; acute exacerbations of chronic bronchitis and community acquired pneumonia · skin and skin structure infections · non-gonococcal urethritis. children roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis, acute tonsillitis and impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - ranitidine hydrochloride 168mg equivalent to ranitidine 150 mg;   - film coated tablet - 150 mg - active: ranitidine hydrochloride 168mg equivalent to ranitidine 150 mg   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry white ys-22-18096 purified water

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - tramadol hydrochloride 150mg - modified release tablet - 150 mg - active: tramadol hydrochloride 150mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide hyprolose magnesium stearate - relief of moderate to severe pain

New Zealand - English - Medsafe (Medicines Safety Authority)

aurobindo pharma nz limited - quetiapine fumarate 172.683mg equivalent to 150 mg quetiapine - film coated tablet - 150 mg - active: quetiapine fumarate 172.683mg equivalent to 150 mg quetiapine excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose opacode black s-1-17823 opadry yellow 03b82924 povidone purified talc sodium starch glycolate - acute and chronic psychoses, including schizophrenia.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - bicalutamide - oral tablet - 150mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

new medical centre trading united arab emirates - 30's (10's blister x 3) - tablet - 150 mg/tablet - cardiovascular system-hypertension , heart failure

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

new medical centre trading united arab emirates - 30's (10's blister x 3) - capsule - 150 mg/capsule - central nervous system-antiepileptics

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

new medical centre trading united arab emirates - 30's (10's blister x 3) - tablet - 150/12.5 mg per tablet - cardiovascular system-hypertension , heart failure

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

new medical centre trading united arab emirates - 30's (10's blister x 3) - tablet - 150 mg / tablet - cardiovascular system-hypertension , heart failure

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c germany - 30's (10's blister x 3) - tablet - 150 mg/tablet - nutrition , blood-vitamins